UBS AG (AMUB) Form 424B3 — Nov 2, 2026
UBS AG filed Amendment No. 1 to the October 30, 2026 pricing supplement for a structured notes offering with a maximum aggregate offering price of $2,151,000, distributed through affiliate UBS Securities LLC under FINRA Rule 5121 conflict-of-interest procedures. The document consists mainly of tax disclosures covering Section 1260, Section 871(m) withholding, the 3.8% Medicare surtax, and FATCA, noting the IRS obsoleted Notice 2008-2 in 2026 but that future guidance could affect taxation of the notes, possibly retroactively. The offering is not available to EEA or UK retail investors, and UBS Securities LLC will not pay additional amounts if withholding is imposed.
Key figures
- Gross Proceeds
- 2151000
- Medicare tax rate
- 3.8%
- Withholding tax rate
- 30%
- Estimated value decay period months
- 6
- Minimum advisory purchase price per note
- $981.50
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.